XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2021   60,898,451              
Beginning balance at Jan. 31, 2021 $ (5,033) $ 61 $ 932,332 $ (1,319) $ (704) $ (935,403) $ (256,746) $ (309,381) $ 52,635
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock option exercises (in shares)   483,787              
Stock option exercises $ 3,540 $ 1 $ 3,539            
Vesting of early exercised stock options (10,000)   (10,000)            
Vesting of restricted stock units (in shares)   341,939              
Vesting of restricted stock units $ 0                
Stock-based compensation 50,914   $ 50,914            
Conversion of 2024 convertible senior notes (in shares)   372,096              
Conversion of convertible senior notes 2,999   2,999            
Unrealized (loss) gain on available-for-sale securities 34       34        
Foreign currency translation adjustment (90)       (90)        
Net loss (63,992)         (63,992)      
Ending balance (in shares) at Apr. 30, 2021   62,096,273              
Ending balance at Apr. 30, 2021 $ (268,364) $ 62 680,413 (1,319) (760) (946,760)      
Beginning balance (in shares) at Jan. 31, 2022 67,444,360 67,444,360              
Beginning balance at Jan. 31, 2022 $ 666,700 $ 67 1,860,514 (1,319) (2,928) (1,189,634)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock option exercises (in shares) 235,517 235,517              
Stock option exercises $ 1,656   1,656            
Vesting of restricted stock units (in shares)   381,178              
Vesting of restricted stock units 1 $ 1              
Stock-based compensation 83,566   83,566            
Conversion of 2024 convertible senior notes (in shares)   8              
Conversion of convertible senior notes 1   1            
Unrealized (loss) gain on available-for-sale securities (2,364)       (2,364)        
Foreign currency translation adjustment 613       613        
Net loss $ (77,294)         (77,294)      
Ending balance (in shares) at Apr. 30, 2022 68,061,063 68,061,063              
Ending balance at Apr. 30, 2022 $ 672,879 $ 68 $ 1,945,737 $ (1,319) $ (4,679) $ (1,266,928)